Alnylam announces launch of “alnylam challengers,” a signature community impact program to improve health access to underserved communities

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, today announced the launch of alnylam challengers, a signature community impact program that will support bold and diverse organizations in their pursuit of developing new and sustainable solutions to address challenges in health equity. through this program, alnylam will collaborate with social entrepreneurs, employees, and business partners to create innovative health soluti
ALNY Ratings Summary
ALNY Quant Ranking